The Ohlthaver & List (O&L) Group has announced the appointment of Dr Christina Swart-Opperman as a Non-Executive Director to the Board of Ohlthaver List Finance Trading (Pty) Ltd (OLFITRA) , effective 1 April 2025.
Dr Swart-Opperman has been a key figure within the O&L Group since 2016, notably serving as Chairperson of the OLFITRA Remuneration and Nomination Committee (REMCO).
Her role in this capacity has been instrumental in shaping the Group’s remuneration philosophy, with a focus on fairness, strategic alignment, and excellence in talent management.
Recognised as a pioneer in Namibia’s corporate sector, Dr Swart-Opperman founded the country’s first Human Resource Consulting practice and broke ground as the first female partner at PwC Namibia.
Beyond the boardroom, she is also known for her philanthropic work through the Christina Swart-Opperman Aids Orphan Foundation Trust, which supports vulnerable children affected by HIV/AIDS.
Her academic background includes a PhD focused on innovation and team dynamics, reflecting her deep expertise in business strategy, leadership, and people development.
Dr Swart-Opperman joins an experienced OLFITRA Board, which comprises Executive Chairman and Chairperson of the Board Sven Thieme, Chief Operations Officer Wynand Oosthuizen, Chief Experience Officer Franziska Rüeck, Chief Human Capital Officer Terence Makari, Chief Financial Officer Theresa Weitz, and Corporate Affairs Manager Gideon Shilongo. The Non-Executive Directors include Günther Hanke, Berthold Mukuahima, Hans-Harald Müseler and Peter Grüttemeyer.
Commenting on the appointment, Sven Thieme, O&L Group Executive Chairman and Chairperson of the OLFITRA Board, said:“Dr Swart-Opperman’s appointment is a testament to O&L’s commitment to strong leadership, sustainable business practices and purpose-driven stakeholder engagement. We are confident that her wealth of knowledge, experience and passion will further strengthen our O&L Persona characteristics of being Authentic, Caring and Passionate.”
He added: “We warmly congratulate Dr Swart-Opperman on this well-deserved appointment and look forward to her continued impact within the O&L Family.”
